OrbiMed’s Altimmune ALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-100,000	Closed	-$260K	–	112
2023 Q3	$260K	Hold	100,000	–	–	0.01%	118
2023 Q2	$353K	Buy	100,000 +49,400	+98%	+$174K	0.01%	119
2023 Q1	$214K	Buy	+50,600	New	+$214K	﹤0.01%	116